Wave Life Sciences Ltd. (WVE) Financials

WVE Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 558.3 million 104.8 million
March 31, 2026 583.5 million 71.8 million
Dec. 31, 2025 638.5 million 112.3 million
Sept. 30, 2025 241.4 million 116.8 million

WVE Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -49.2 million 10.7 million
March 31, 2026 -60.0 million 9.1 million
Dec. 31, 2025 -32.1 million -17.6 million
Sept. 30, 2025 -44.9 million 6.5 million

WVE Net Income

No data available :(

WVE Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 490.6 million - 43.6 million
March 31, 2026 544.6 million - 15.7 million
Dec. 31, 2025 602.1 million - 17.8 million
Sept. 30, 2025 196.2 million - 19.8 million

WVE Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 202.1 million
March 31, 2026 200.2 million
Dec. 31, 2025 180.2 million
Sept. 30, 2025 167.7 million

WVE Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 884000 51.3 million 24.8 million -
March 31, 2026 438000 47.4 million 22.1 million -
Dec. 31, 2025 10009 52.8 million 20.9 million -
Sept. 30, 2025 248000 45.9 million 18.1 million -

WVE Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 2.3 million -
March 31, 2026 38.2 million -
Dec. 31, 2025 17.2 million 2.3 million
Sept. 30, 2025 7.6 million -

WVE

Price: $3.13

52 week price:
3.09
21.73

Earnings Per Share: -1.12 USD

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Country: Singapore

Volume: 358300

Ebitda: -26.4 million

Market Capitalization: 697.5 million

Links: